Unio Capital LLC Gilead Sciences, Inc. Transaction History

Unio Capital LLC

$240 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $7.84 Million - $8.83 Million	-135,823 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $143,873 - $180,288	-2,484 Reduced 1.8%	135,823 $611 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $442,092 - $501,782	6,814 Added 5.18%	138,307 $783 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $58,010 - $62,586	-857 Reduced 0.65%	131,493 $9.19 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $453,429 - $495,436	-7,144 Reduced 5.12%	132,350 $9.11 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $15,000 - $17,115	250 Added 0.18%	139,494 $9.02 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.35 Million - $2.68 Million	41,519 Added 42.49%	139,244 $8.11 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $547,535 - $688,431	8,817 Added 9.92%	97,725 $5.94 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2.17 Million - $2.52 Million	-29,975 Reduced 25.21%	88,908 $6.84 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $574,818 - $736,259	-9,178 Reduced 7.17%	118,883 $8.89 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $221,523 - $243,669	3,595 Added 2.89%	128,061 $8.32 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $557,776 - $615,687	8,923 Added 7.72%	124,466 $7.89 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $527,936 - $592,019	8,533 Added 7.97%	115,543 $7.92 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $368,051 - $412,314	5,886 Added 5.82%	107,010 $6.96 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $273,398 - $356,764	-4,516 Reduced 4.27%	101,124 $6.33 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $695,051 - $769,548	9,751 Added 10.17%	105,640 $8.16 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $625,702 - $729,857	9,644 Added 11.18%	95,889 $6.79 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $966,951 - $1.18 Million	13,275 Added 18.19%	86,245 $6.5 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $5.19 Million - $6.09 Million	72,970	72,970 $5.23 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unio Capital LLC with notifications on news.

Account